Title:
遺伝子発現シグネチャーに基づいて2型糖尿病に対する薬物を同定するプロトコル
Document Type and Number:
Japanese Patent JP2012518989
Kind Code:
A
Abstract:
It relates generally to the field of drug identification and evaluation and therapeutic optimization. More particularly, it provides a protocol for identifying compounds useful in the treatment of TNFα associated diabetes or a condition associated with diabetes based on a signature of genomic or proteomic expression. Diagnostic and prognostic protocols for diabetes and conditions associated therewith are also provided. Further, optimization of therapeutic intervention is also provided.
More Like This:
JP2005204664 | DETECTION OF ENTEROVIRUS NUCLEIC ACID |
JP2005237273 | METHOD FOR EVALUATING HAIR GROWER |
WO/1997/002361 | A METHOD FOR DETERMINING THE INTEGRITY OF NUCLEIC ACID |
Inventors:
Walder Ken
Constant Pourros Nicky
Collier Greg Lois
Constant Pourros Nicky
Collier Greg Lois
Application Number:
JP2011551372A
Publication Date:
August 23, 2012
Filing Date:
February 25, 2010
Export Citation:
Assignee:
Bellba Pharmaceuticals Limited
International Classes:
C12Q1/68; A61K45/00; A61P3/10; C12Q1/02; G01N33/15; G01N33/50; G01N33/68; C12N15/09
Attorney, Agent or Firm:
Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Shinichi Watanabe
Masato Ozeki
Yoshihiro Igarashi
Kazuya Kawamoto
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Shinichi Watanabe
Masato Ozeki
Yoshihiro Igarashi
Kazuya Kawamoto